CMRA Comera Life Sciences Holdings, Inc.
Partial data0.0001USD0.00%Mkt Cap: 3073 $P/E: —20d ago
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is desi…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap3.07K USD
Enterprise Value3.12M USD
Revenue (TTM)1.00M USD
Gross Profit422.71K USD
Net Income (TTM)-18.00M USD
Revenue/Share0.05 USD
Last Price0.0001 USD
Fiscal Year EndDec 2022
MR QuarterSep 2023
Employees12
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.41
EV/Revenue3.12
P/S0.00
P/B-0.00
EPS (TTM)-0.22
EPS (Forward)—
52W Range
0.00010% of range0.0002
52W High0.0002 USD
52W Low0.0001 USD
Profitability
Gross Margin66.77%
Oper. Margin-1582.47%
EBITDA Margin0.00%
Profit Margin-2843.79%
ROE288.20%
ROA-483.06%
Growth
Revenue Growth-42.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.77M USD
CapEx (TTM)28.61K USD
FCF Margin-298.77%
FCF Yield-97262.19%
Net Debt-1.21M USD
Net Debt/EBITDA0.16
Balance Sheet
Debt/Equity-0.05
Current Ratio0.90
Quick Ratio0.64
Book Value/Sh-0.14 USD
Cash/Share0.06 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.30.74M
Float13.53M
Insiders62.18%
Institutions0.00%
Short Interest
Short Ratio0.8d
Short % Float1.36%
Short % Out.0.92%
Shares Short281.55K
Short (prev mo.)27.93K
Technical
SMA 500.0001 (-0.0%)
SMA 2000.0001 (-0.0%)
Beta-86.15
S&P 52W Chg13.94%
Avg Vol (30d)0
Avg Vol (10d)3.15K
Technical Indicators
RSI (14)100.0
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.0001 USD
BB Middle0.0001 USD
BB Lower0.0001 USD
BB Width0.00%
ATR (14)0.0000 USD
Vol Ratio (20d)—